# US 2024/0002801 A1 · Mass proliferation culture method of nk cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002801 A1
- Document ID: US20240002801A1
- Status: Published application
- Kind: A1
- Application number: 18/252,572
- Filed: 2021-05-10
- Published: 2024-01-04
- Earliest claimed: 2020-11-11
- Assignees: Hanbio Co., Ltd.
- Applicants: Hanbio Co., Ltd.
- Inventors: Da Witt KANG; Hyun Chul KANG
- Web page: https://patentgrep.com/patent/US20240002801A1

## CPC

- C12N 5/0646: {Natural killers cells [NK], NKT cells}
- C12N 5/0081: {Purging biological preparations of unwanted cells}
- C12N 2501/2302: Interleukin-2 (IL-2)
- C12N 2501/2315: Interleukin-15 (IL-15)
- C12N 2501/599: with CD designations not provided for elsewhere
- C12N 2506/11: from blood or immune system cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a culture method of NK cell, the method comprising: 1) isolating a pellet of peripheral blood mononuclear cell (PBMC) containing immune cells from blood by using ficoll and centrifugation; 2) culturing the isolated PBMC in an anti-CD16 antibody-coated incubator in a medium containing RPMI culture medium, plasma, IL-2, IL-15, anti-CD56, anti-NKp46, and anti-NKp30; 3) subculturing the cultured PBMC in RPMI medium, albumin, IL-2, IL-15, anti-CD56, anti-NKp46, and anti-NKp30; and 4) treating the subcultured PBMC in a medium composition based on RPMI to which anti-NKp30, anti-NKp46 and anti-CD56 antibodies are added with a cytokine selected from a cytokine group consisting of IL-2, IL-15, and IL-2+IL-15 to activate NK cells. The present invention is an optimal combination that can effectively activate cells when NK cells are treated with IL-2 and IL-15 among various cytokines, and when treated with IL-2+IL-15, mass culture of NK cells is possible. Since apoptosis or killing ability of cancer cells can be promoted when this is used, the present invention can be used as an effective immune cell therapy for preventing or treating cancer.

## Claims

### Claim 1

A culture method of NK cell, the method comprising: 1) isolating a pellet of peripheral blood mononuclear cell (PBMC) containing immune cells from blood by using ficoll and centrifugation;
2) culturing the isolated PBMC in an anti-CD16 antibody-coated incubator in a medium containing RPMI culture medium, plasma, IL-2, IL-15, anti-CD56, anti-NKp46, and anti-NKp30;
3) subculturing the cultured PBMC in RPMI medium, albumin, IL-2, IL-15, anti-CD56, anti-NKp46, and anti-NKp30; and
4) treating the subcultured PBMC in a medium composition based on RPMI to which anti-NKp30, anti-NKp46 and anti-CD56 antibodies are added with a cytokine selected from a cytokine group consisting of IL-2, IL-15, and IL-2+IL-15 to activate NK cells.

### Claim 2 (depends on 1)

The culture method of NK cell according to claim 1, wherein the cytokine of the Step 4) is treated with IL-2+IL-15.

### Claim 3 (depends on 2)

The culture method of NK cell according to claim 2, wherein the cytokine of the Step 4) is treated with IL-2 20 ng/ml and IL-15 50 ng/ml.

### Claim 4 (depends on 1)

The culture method of NK cell according to claim 1, wherein red blood cells are removed by treating an immune cell pellet with an RBC lysis buffer when isolating immune cells in the Step 1).

### Claim 5 (depends on 1)

The culture method of NK cell according to claim 1, wherein the culturing in the Step 2) is carried out in a T25 flask coated with anti-CD16 antibody when the cell number is 3×10 7 or less and in a T75 flask coated with anti-CD16 antibody when the cell number is 3×10 7 or more by adding RPMI 8 ml, plasma 2 ml, IL-2 20 ng/ml, IL-15 50 ng/ml, anti-CD56 5 ng/ml, anti-NKp46 5 ng/ml, and anti-NKp30 5 ng/ml, suspending PBMC pellet in 10 ml RPMI and further adding the mixture, and culturing in an incubator at 37° C. and 5% CO2 for 3 to 4 days.

### Claim 6 (depends on 1)

The culture method of NK cell according to claim 1, wherein the subculturing in the Step 3) is preferably carried out by adding the cell culture suspension of the Step 2) 20 ml, RPMI 72 ml, albumin 8 ml, IL-2 20 ng/ml, IL-15 50 ng/ml, anti-NKp30 5 ng/ml, anti-NKp46 5 ng/ml, and anti-CD56 5 ng/ml and culturing in an incubator at 37° C. and 5% CO2 for 3 to 5 days in primary subculture; and by adding primary subculture suspension 50 ml, RPMI 180 ml, albumin 20 ml, IL-2 20 ng/ml, IL-15 50 ng/ml, anti-NKp30 5 ng/ml, anti-NKp46 5 ng/ml, and anti-CD56 5 ng/ml and culturing in an incubator at 37° C. and 5% CO2 for 5 to 7 days in secondary subculture.
